HLB
HLB, established in 1985, is a corporate investor based in Seoul. It invests in sectors including Healthcare, Biotechnology, and pharmaceuticals. HLB operates as a global biopharmaceutical company.
HLB
HLB, established in 1985, is a corporate investor based in Seoul. It invests in sectors including Healthcare, Biotechnology, and pharmaceuticals. HLB operates as a global biopharmaceutical company.
General information
Firm type
Corporate Investor
Year founded
1985
AUM
—
Location
Region
—
Country
—
City
Ulsan
Corporate office
10-5 Myeonghaksandanseo-ro Yeondong-myeon
Frequently asked questions
What is HLB?
HLB is a corporate investor headquartered in Ulsan.
When was HLB founded?
HLB was founded in 1985.
Where is HLB headquartered?
HLB is headquartered in Ulsan.
What does Altss track for HLB?
Altss maintains an OSINT-verified profile of HLB covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), assets (real estate, public market positions, private companies, art and cultural holdings, philanthropy and foundations), and network (club memberships, associations, and event participation). Detailed values are available to Altss subscribers.
What is HLB's website?
HLB's public website is hlbbio.co.kr. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is HLB?
HLB is classified by Altss as a Corporate Investor.
How does Altss source intelligence on HLB?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
How fresh is the Altss profile for HLB?
HLB's profile is part of Altss's continuous-refresh dataset, with a full update cycle at least every 30 days and priority changes applied as new information is verified.
Company types
Confirmed
Pipeline
Indicated
Negative
Industry focuses
Confirmed
Pipeline
Indicated
Negative
Regional focuses
Confirmed
Pipeline
Indicated
Negative
Technological focuses
Confirmed
Pipeline
Indicated
Negative
Get access to Altss to unlock details
Get accessInvestment stages
Confirmed
Pipeline
Indicated
Negative
Emerging interests
Hard exclusions
ESG policy
Direct deal program
Emerging manager LP program
Get access to Altss to unlock details
Get accessManager maturity preference
Confirmed
Indicated
Ticket size (USD M, min/max)
Preferred fund size (USD M, min/max)
Investment horizon (years, min/max)
Target IRR (%)
Max leverage
Liquidity terms
Currency preference
Get access to Altss to unlock details
Get accessPhilanthropy-only themes
Political donations
Service Providers & Advisors
| Category | Firm | Years Active | Primary Contact |
|---|---|---|---|
Company Deals
| Date | Company | Type | Sector | Geography | Role | Amount | Deal Lead | Co-investors | Insight |
|---|---|---|---|---|---|---|---|---|---|
Get access to Altss to unlock details
Get accessFund Commitments
| Date | Fund | Strategy | Geography | Role | Fund size | Vintage |
|---|---|---|---|---|---|---|
Club Memberships and Associations & Advisors
| Organization | Role | Since | Notes |
|---|---|---|---|
Get access to Altss to unlock details
Get accessEvent & Conference Participation
| Event | Role | Date | Location |
|---|---|---|---|
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: